Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: Manhasset, New York 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Tau Networks in Psychotic Alzheimer's Disease
N/AOBSERVATIONAL Manhasset, New York
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
ACP-204 in Adults With Alzheimer's Disease Psychosis
PHASE2, PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
PHASE2INTERVENTIONAL Englewood, New Jersey
RECRUITING
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
PHASE2, PHASE3INTERVENTIONAL Murrieta, California +4 more
RECRUITING
Aβ Dynamics in LLMD
PHASE4INTERVENTIONAL New York, New York +1 more
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
NAINTERVENTIONAL Delray Beach, Florida +4 more
RECRUITING
NYSCF Scientific Discovery Biobank
N/AOBSERVATIONAL New York, New York
RECRUITING
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
PHASE2INTERVENTIONAL New York, New York
RECRUITING
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Early Age-Related Hearing Loss Investigation (EARHLI)
NAINTERVENTIONAL New York, New York
RECRUITING
Filter Trials
Trial Phase
Study Type